Food and Drug Administration inspectors found problems with record keeping and quality controls for animal experiments at Elon Musk’s Neuralink, less than a month after the startup said it was cleared ...

Neuralink is building a brain implant that lets people control computers by thought. The pitch is bold, and the demos look impressive. Yet the road to those moments has been rough. Early research used ...

The FDA found some "record keeping and quality controls" issues at a Neuralink animal-testing site, Reuters reported. The issues, reportedly discovered at a California facility, were not significant ...

(Reuters) - An animal testing laboratory at Elon Musk's Neuralink brain technology company was found to have "objectionable conditions or practices" by the Food and Drug Administration, which cited ...

WASHINGTON, Feb 29 (Reuters) - U.S. Food and Drug Administration inspectors found problems with record keeping and quality controls for animal experiments at Elon Musk's Neuralink, less than a month ...

Tom has a Master's degree in Journalism. His editorial work covers anything from archaeology and the environment to technology and culture. Tom has a Master's degree in Journalism. His editorial work ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. A ...

Brain-computer interfaces (BCI) sound like science fiction to most people. But this technology is getting real, quickly.

Neuralink, the tech startup founded by Elon Musk, implanted a brain chip in its first human patient. Musk made the announcement on his social media platform "X" on Monday, saying the person is in the ...

Elon Musk's Neuralink faced scrutiny from the US Food and Drug Administration shortly after the billionaire said the regulator had approved the startup for human trials of its brain chips, according ...

An animal testing laboratory at Elon Musk’s Neuralink brain technology company was found to have “objectionable conditions or practices” by the Food and Drug Administration, which cited the company ...